key: cord-0941970-6i2ca89d
authors: Ali, Mohammad A.M
title: The platelet in COVID-19: a critical participant or a bystander?
date: 2021-09-14
journal: Trends Cardiovasc Med
DOI: 10.1016/j.tcm.2021.09.004
sha: d408f946b41a309b408c9be6426823d29f75a642
doc_id: 941970
cord_uid: 6i2ca89d

nan

decades and we now realize that platelets are implicated in various pathophysiological conditions including; wound healing, inflammation, carcinogenesis and immune response to viruses (1) . In fact, platelets express hundreds of thousands of receptors on their cell membranes that are important for normal functions. Some of the well-recognized platelets' receptors are integrins, selectins, GPCRs, lipid receptors and immunoglobulin receptors (to name a few) (2) . Many of platelet's receptors are rapidly activated early during infection and accordingly, platelets can be viewed as one of the first line defenses against various pathogens, including viruses (3).

Viruses, in general, initiate their first contact with host cells via viral binding to cell surface receptors. This binding mediates viral internalization through the endocytic pathways, allowing injection of the viral genome into host cells (4). Interestingly, platelets' receptors have been reported to interact with numerous viruses and to mediate viral entry (5) . Although lacking nuclei, platelets retain part of the protein synthesis machinery and are able to synthesize some proteins from transcripts including viral RNAs (6) . Recently, the ACE2 receptor was also found on platelets' surfaces and thus, SARS-CoV2 is able to internalize human platelets and directly activate them (7). This mechanism can provide another explanation of the strong correlation 

Platelets: Versatile effector cells in hemostasis, inflammation, and the immune continuum

Platelet receptors; an instrumental of platelet physiology

Platelets in immune response to virus and immunopathology of viral infections

Cell-free versus cell-to-cell infection by human immunodeficiency virus type 1 and human T-lymphotropic virus type 1: Exploring the link among viral source, viral trafficking, and viral replication

Platelets and viruses: An ambivalent relationship

Protein synthesis by platelets: Historical and new perspectives

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

The roles of platelets in COVID-19-associated coagulopathy and vaccineinduced immune thrombotic thrombocytopenia

Mechanisms of immunothrombosis in vaccineinduced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection

Aspirin use is associated with decreased mechanical ventilation, intensive care unit admission, and in-hospital mortality in hospitalized patients with coronavirus disease 2019

Is aspirin the true protective therapy in coronavirus disease 2019 patients? Anesth Analg

MA is supported by a SUNY startup fund (#910252-50)